MCOV B — Medicover AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK29.21bn
- SEK41.15bn
- €1.75bn
- 78
- 15
- 98
- 72
Annual cashflow statement for Medicover AB, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 33.3 | 37.3 | 144 | 19.8 | 23.6 |
| Depreciation | |||||
| Non-Cash Items | 16.7 | 34.2 | 21.1 | 47.5 | 42.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -36.9 | -11.7 | -59.2 | -59 | -43.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 87.3 | 156 | 217 | 170 | 205 |
| Capital Expenditures | -63.2 | -72.5 | -102 | -141 | -111 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -78.6 | -53.8 | -231 | -44.2 | -9.3 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -142 | -126 | -334 | -185 | -120 |
| Financing Cash Flow Items | -18.7 | -18.2 | -26 | -45.3 | -54.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 48.8 | -14.1 | 164 | -24.3 | -73.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.6 | 11.9 | 35.2 | -41.5 | 10.4 |